Price $397.75 |
Market Cap
61.01B
|
Sector Health Care |
Div. Growth
9.30%
|
|
P/E
11.3
|
P/B
-
|
P/S
0.99
|
Dividend %
1.00%
|
|
P/CF
-
|
P/FCF
17.4
|
Op. Cash Flow
9.28M
|
FCF
13.3
|
|
Op. Margin
14.60%
|
Net Margin
9.00%
|
ROE
-227.70%
|
ROI
20.50%
|
|
ROA
10.70%
|
EPS Growth
14.80%
|
Current Ratio
1.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
| Inotiv Inc (NOTV) | $1.44 | - | - | 46.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
